{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:32:26Z","timestamp":1793082746829,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179426","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:21:21Z","timestamp":1792020081000},"page":"179426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of sitagliptin combined with GTS-21 on improving glycemic control and diabetic nephropathy by anti-apoptosis in Leprdb\/db mice"],"prefix":"10.1016","volume":"1037","author":[{"given":"Weikun","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liye","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1526-1380","authenticated-orcid":false,"given":"Qinghe","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","article-title":"The inhibitory effects of peripheral administration of peptide YY3\u201336 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal\u2013brainstem\u2013hypothalamic pathway","volume":"1044","author":"Abbott","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2026.179426_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104622","article-title":"The cholinergic anti-inflammatory pathway in humans: State-of-the-art review and future directions","volume":"136","author":"Alen","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2026.179426_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cytogfr.2025.05.007","article-title":"Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression","volume":"84","author":"Ansari","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"19","key":"10.1016\/j.ejphar.2026.179426_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030539","article-title":"Vagus nerve stimulation and inflammation in cardiovascular disease: a state-of-the-art review","volume":"12","author":"Bazoukis","year":"2023","journal-title":"JAHA"},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2026.179426_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.08.003","article-title":"The molecular mechanisms of pancreatic \u03b2-cell glucotoxicity: recent findings and future research directions","volume":"364","author":"Bensellam","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2 Suppl. l","key":"10.1016\/j.ejphar.2026.179426_bib6","first-page":"S59","article-title":"Liraglutide: a review of the first once-daily GLP-1 receptor agonist","volume":"17","author":"Bode","year":"2011","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejphar.2026.179426_bib7","series-title":"Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin","author":"Borovikova","year":"2000"},{"issue":"11","key":"10.1016\/j.ejphar.2026.179426_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188797","article-title":"Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice","volume":"12","author":"Chatterjee","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179426_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.regpep.2004.06.007","article-title":"What do we know about the secretion and degradation of incretin hormones?","volume":"128","author":"Deacon","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2026.179426_bib10","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2741\/2799","article-title":"DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes","volume":"13","author":"Deacon","year":"2008","journal-title":"Front. Biosci."},{"issue":"40","key":"10.1016\/j.ejphar.2026.179426_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035397","article-title":"Comprehensive advancements in the prevention and treatment of diabetic nephropathy: a narrative review","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.ejphar.2026.179426_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115260","article-title":"Upregulation of Nrf2\/HO-1 signaling and farnesoid X receptor and attenuation of oxidative stress and inflammation mediate the protective effect of sitagliptin against diabetic nephropathy in rats","volume":"163","author":"Hasan","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13054-025-05599-x","article-title":"DPP4 inhibition curbs systemic inflammation","volume":"29","author":"Hellenthal","year":"2025","journal-title":"Crit. Care"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179426_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41419-023-06206-z","article-title":"Macrophage polarization and metabolism in atherosclerosis","volume":"14","author":"Hou","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.179426_bib15","article-title":"Sitagliptin phosphate ameliorates chronic inflammation in diabetes mellitus via modulating macrophage polarization","volume":"16","author":"Hu","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.179426_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114628","article-title":"Vagus nerve stimulation as immunomodulatory therapy for stroke: a comprehensive review","volume":"372","author":"Jelinek","year":"2024","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179426_bib17","article-title":"Manipulation of the inflammatory reflex as a therapeutic strategy","volume":"3","author":"Kelly","year":"2022","journal-title":"Cell Rep. Med."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2026.179426_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-4328(00)00211-4","article-title":"The brain a7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)","volume":"113","author":"Kem","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2026.179426_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179426_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.physbeh.2015.06.001","article-title":"Vagal mediation of GLP-1\u2019s effects on food intake and glycemia","volume":"152","author":"Krieger","year":"2015","journal-title":"Physiol. Behav."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179426_bib21","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bcp.2008.07.029","article-title":"DPP4 inhibitors for diabetes\u2014What next?","volume":"76","author":"Lambeir","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179426_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/med.21654","article-title":"Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes","volume":"40","author":"Le Bagge","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179426_bib25","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.immuni.2025.06.003","article-title":"Optogenetic vagal nerve stimulation attenuates heart failure by limiting the generation of monocyte-derived inflammatory CCRL2+ macrophages","volume":"58","author":"Li","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2026.179426_bib24","article-title":"Roles and crosstalks of macrophages in diabetic nephropathy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41420-021-00431-1","article-title":"Vagus nerve stimulation enhances the cholinergic anti-inflammatory pathway to reduce lung injury in acute respiratory distress syndrome via STAT3","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179426_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00592-023-02088-x","article-title":"Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes","volume":"60","author":"Longo","year":"2023","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2119\/molmed.2013.00117","article-title":"\u03b17 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release","volume":"20","author":"Lu","year":"2014","journal-title":"Mol Med"},{"key":"10.1016\/j.ejphar.2026.179426_bib30","article-title":"Macrophage polarization: an important role in inflammatory diseases","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179426_bib29","first-page":"397","article-title":"Research progress on the potential mechanisms and effects of the cholinergic anti-inflammatory pathway in sepsis","volume":"37","author":"Luo","year":"2025","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-23583-x","article-title":"\u03b17 nicotinic acetylcholine receptor agonist attenuates lipopolysaccharide-induced acute kidney injury in mice by reducing CCL2 expression in macrophages","volume":"15","author":"Matsuo","year":"2025","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179426_bib32","first-page":"3969","article-title":"Molecular targets of novel therapeutics for diabetic kidney disease: a new era of nephroprotection","volume":"25","author":"Mazzieri","year":"2024","journal-title":"Int. J. Math. Stat."},{"key":"10.1016\/j.ejphar.2026.179426_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179426_bib35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/dom.14693","article-title":"The alpha\u20107 nicotinic acetylcholine receptor agonist GTS \u201021 engages the glucagon\u2010like peptide\u20101 incretin hormone axis to lower levels of blood glucose in db\/db mice","volume":"24","author":"Meng","year":"2022","journal-title":"Diabetes Obes. Metabol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42665-2","article-title":"Galantamine improves glycemic control and diabetic nephropathy in Leprdb\/db mice","volume":"13","author":"Meng","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-27015-y","article-title":"GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Leprdb\/db mice","volume":"12","author":"Meng","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179426_bib37","first-page":"1094","article-title":"Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the Most important complications","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int. J. Math. Stat."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179426_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/SHK.0000000000000519","article-title":"Effect OF GTS-21, an ALPHA7 nicotinic acetylcholine receptor agonist, on clp-induced inflammatory, gastrointestinal motility, and colonic permeability changes in mice","volume":"45","author":"Nullens","year":"2016","journal-title":"Shock"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179426_bib39","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bcp.2007.07.015","article-title":"Treating schizophrenia symptoms with an \u03b17 nicotinic agonist, from mice to men","volume":"74","author":"Olincy","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179426_bib40","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15257","article-title":"Blood glucose modulation and safety of efferent vagus nerve stimulation in a type 2 diabetic rat model","volume":"10","author":"Payne","year":"2022","journal-title":"Physiological Reports"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179426_bib41","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179426_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119034","article-title":"Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system","volume":"10","author":"Richard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179426_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101175","article-title":"The gut\u2013brain axis: identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders","volume":"46","author":"Richards","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejphar.2026.179426_bib44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.redox.2017.01.013","article-title":"Mitochondrial dynamics in type 2 diabetes: pathophysiological implications","volume":"11","author":"Rovira-Llopis","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179426_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2011.10.008","article-title":"The role of the gut\/brain axis in modulating food intake","volume":"63","author":"Sam","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179426_bib47","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fendo.2018.00754","article-title":"The regulation of peripheral metabolism by gut-derived hormones","volume":"9","author":"Sun","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.179426_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40168-021-01097-8","article-title":"Novel insights into the genetically obese (ob\/ob) and diabetic (db\/db) mice: two sides of the same coin","volume":"9","author":"Suriano","year":"2021","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179426_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/met.2004.2.82","article-title":"The metabolic syndrome and inflammation","volume":"2","author":"Sutherland","year":"2004","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179426_bib51","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nri2566","article-title":"Reflex control of immunity","volume":"9","author":"Tracey","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179426_bib52","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/en.2018-00433","article-title":"\u03b17 nicotinic acetylcholine receptor regulates the function and viability of L cells","volume":"159","author":"Wang","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2026.179426_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155019","article-title":"GTS-21 ameliorates polymicrobial sepsis-induced hepatic injury by modulating autophagy through \u03b17nAchRs in mice","volume":"128","author":"Wu","year":"2020","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179426_bib54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gendis.2020.08.009","article-title":"Ccrl2 deficiency deteriorates obesity and insulin resistance through increasing adipose tissue macrophages infiltration","volume":"9","author":"Xu","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.ejphar.2026.179426_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172795","article-title":"Contribution of cathepsin B-dependent Nlrp3 inflammasome activation to nicotine-induced endothelial barrier dysfunction","volume":"865","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179426_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12882-025-03953-3","article-title":"New insights in the treatment of DKD: recent advances and future prospects","volume":"26","author":"Zhao","year":"2025","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ejphar.2026.179426_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114561","article-title":"GTS-21 alleviates sepsis-induced atrial fibrillation susceptibility by modulating macrophage polarization and Neuregulin-1 secretion","volume":"154","author":"Zhou","year":"2025","journal-title":"Int. Immunopharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:32:46Z","timestamp":1793079166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926009088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S0014299926009088"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179426","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of sitagliptin combined with GTS-21 on improving glycemic control and diabetic nephropathy by anti-apoptosis in Leprdb\/db mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179426"}}